AVROXA
Technologiepark-Zwijnaarde 82
9052 Gent
BE
AVROXA
Foundation date
10/01/2018
Sector
#Medical TechnologySubsector
- #Medtech - Biomaterials
- #Medtech - Coatings
- #Medtech - Delivery devices
- #Medtech - Diagnostic devices
- #Medtech - Non-active implantable devices
- #Medtech - Regenerative Medicine
AVROXA is a research and manufacturing company committed to the development of innovative solutions based on our versatile proprietary polymer platform technology of poly(2-oxazoline)s (abbreviated as POZ, PAOx,POX). We develop a vast range of high-quality, well-defined, ultra-pure poly(2-oxazoline)s under the brandname ULTROXA(R) for applications in therapeutics, drug delivery, biomaterials and diagnostics.
Upcoming events
All events-
1804 '24
Anglonordic Life Science Conference 2024
Event by: BioPartner -
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
2304 '24
BioTrinity 2024
Event by: OBN
Latest news
More news-
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
1 day ago
Read more
-
InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline
Tuesday March 26th 2024
Read more
-
Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy
Monday March 25th 2024
Read more
Jobs
More jobs-
28/03/24
Flemish Brabant
Post-doc position – Structural Bioinformatics of protein interactions
Permanent
VIB -
-
More info?
Ellen Telleir
Communication Coordinator